- inhaler:
Fluticasone furoate (Arnuity
Ellipta,
Relvar Ellipta)
Fluticasone furoate/vilanterol (Breo
Ellipta,
Relvar Ellipta)
Fluticasone furoate/umeclidinium...
-
marketed as
Trelegy Ellipta, and
fluticasone furoate/vilanterol,
marketed as Breo
Ellipta (US, Canada, New Zealand) and
Relvar Ellipta (EU, UK), are approved...
-
Fluticasone furoate/vilanterol, sold
under the
brand name Breo
Ellipta among others, is a
combination medication for the
treatment of
chronic obstructive...
-
Umeclidinium bromide/vilanterol, sold
under the
brand name
Anoro Ellipta,
among others, is a fixed-dose
combination medication for the
treatment of chronic...
-
Umeclidinium bromide, sold
under the
brand name
Incruse Ellipta, is a long-acting
muscarinic antagonist approved for the
maintenance treatment of chronic...
-
approved in May 2013 in
combination with
fluticasone furoate for sale as Breo
Ellipta by
GlaxoSmithKline for the
treatment of
chronic obstructive pulmonary disease...
- furoate/umeclidinium bromide/vilanterol, sold
under the
brand name
Trelegy Ellipta among others, is a fixed-dose
combination inhaled medication that is used...
- (amoxicillin)
Anectine (suxamethonium chloride)
Anoro Ellipta (umeclidinium and vilanterol)
Arnuity Ellipta (fluticasone furoate)
Augmentin (amoxicillin/clavulanate...
- bromide—Anoro
Ellipta with
fluticasone furoate—Breo
Ellipta (U.S.),
Relvar Ellipta (EU, RU) with
fluticasone furoate and
umeclidinium bromide—Trelegy
Ellipta isoxsuprine...
-
component of
combination drugs: with
fluticasone furoate: Breo
Ellipta (U.S.),
Relvar Ellipta (EU, RU). This
second medication in this
combination is the...
